Notify me when Sofinnova Crossover I files a new Schedule 13D/G report.
⭐ Subscribe ⭐| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| ABVX | Abivax SA | Ordinary Shares, par value (euro)0.01 per share | 9.4% | $713M | -$102M | 8.4M | -12.5% | Sofinnova Crossover I SLP | 28 Oct 2025 |
| IVA | Inventiva, S.A. | Ordinary Shares, nominal value (euro)0.01 per share | 7.2% | $24.5M | 7.79M | Sofinnova Crossover I SLP | 31 Dec 2024 |
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Filing Date |
|---|